Development of a personalized decision aid for breast cancer risk reduction and management

BMC Medical Informatics and Decision Making

Volumn 14, Issue 1, 2014, Pages

  Ozanne, Elissa M ^a,b   Howe, Rebecca ^a   Omer, Zehra ^c   Esserman, Laura J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Breast cancer; Decision aid; Decision making; Primary care; Risk assessment; Risk reduction

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; DECISION MAKING; DECISION SUPPORT SYSTEM; DISEASE MANAGEMENT; EQUIPMENT; FEMALE; HUMAN; INFORMATION PROCESSING; INTERNET; MALE; MIDDLE AGED; PATIENT CARE; RISK ASSESSMENT; RISK REDUCTION; STANDARD; UTILIZATION REVIEW;

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DECISION SUPPORT TECHNIQUES; DISEASE MANAGEMENT; FEMALE; FOCUS GROUPS; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 84892408713     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/1472-6947-14-4     Document Type: Article

References (36)

1. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH, J Natl Cancer Inst 2003 95 526 532 10.1093/jnci/95.7.526 12671020 (Pubitemid 36511623)
2. Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, Cancer Prev Res (Phila) 2010 3 696 706 10.1158/1940-6207.CAPR-10-0076 20404000
3. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Fagerlin A, Dillard AJ, Smith DM, Zikmund-Fisher BJ, Pitsch R, McClure JB, Greene S, Alford SH, Nair V, Hayes DF, Wiese C, Ubel PA, Breast Cancer Res Treat 2011 127 681 688 10.1007/s10549-011-1450-1 21442198
4. Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Waters EA, Cronin KA, Graubard BI, Han PK, Freedman AN, Cancer Epidemiol Biomarkers Prev 2010 19 443 446 10.1158/1055-9965.EPI-09-0930 20142242
5. Factors affecting breast cancer risk reduction practices among California physicians. Kaplan CP, Haas JS, Pérez-Stable EJ, Des Jarlais G, Gregorich SE, Prev Med (Baltim) 2005 41 7 15 (Pubitemid 40755058)
6. Use of medications to reduce risk for primary breast cancer: a systematic review for the US: preventive services task force. Nelson HD, Smith MEB, Griffin JC, Fu R, Ann Intern Med 2013 158 8 604 614 10.7326/0003-4819-158-8- 201304160-00005 23588749
7. Decision aids for people facing health treatment or screening decisions. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R, Cochrane Database Syst Rev 2011 10 D001431
8. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR, Med Decis Making 2007 27 554 574 10.1177/0272989X07307319 17873255 (Pubitemid 47547608)
9. Annotated bibliography: studies evaluating decision-support interventions for patients. O'Connor AM, Drake ER, Fiset VJ, Page J, Curtin D, Llewellyn-Thomas HA, Can J Nurs Res 1997 29 113 120
10. Health decision aids to facilitate shared decision making in office practice. Barry MJ, Ann Intern Med 2002 136 127 135 10.7326/0003-4819-136-2- 200201150-00010 11790064 (Pubitemid 34073937)
11. The potential benefits of decision aids in clinical medicine. Edwards A, Elwyn G, JAMA 1999 282 779 780 10.1001/jama.282.8.779 10463715 (Pubitemid 29404386)
12. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Wakefield CE, Meiser B, Homewood J, Taylor A, Gleeson M, Williams R, Tucker K, Psychooncology 2008 17 844 854 10.1002/pon.1353 18613319
13. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Wakefield CE, Meiser B, Homewood J, Peate M, Taylor A, Lobb E, Kirk J, Young M-A, Williams R, Dudding T, Tucker K, Breast Cancer Res Treat 2008 107 289 301 10.1007/s10549-007-9539-2 17333332 (Pubitemid 350265688)
14. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Van Roosmalen MS, Stalmeier PFM, Verhoef LCG, Hoekstra-Weebers JEHM, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WAJ, J Clin Oncol 2004 22 3293 3301 10.1200/JCO.2004.05.066 15310772 (Pubitemid 41103685)
15. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, Mauger DT, JAMA 2004 292 442 452 10.1001/jama.292.4.442 15280342 (Pubitemid 38988953)
16. Online tool to guide decisions for BRCA1/2 mutation carriers. Kurian AW, Munoz DF, Rust P, Schackmann EA, Smith M, Clarke L, Mills MA, Plevritis SK, J Clin Oncol 2012 30 497 506 10.1200/JCO.2011.38.6060 22231042
17. Informed decision making in outpatient practice: time to get back to basics. Braddock CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W, JAMA 1999 282 2313 2320 10.1001/jama.282.24.2313 10612318 (Pubitemid 30013062)
18. Decision analysis and the evaluation of decision technologies. Dowie J, Qual Health Care 2001 10 1 2 11239135 (Pubitemid 32242708)
19. Management of the high-risk patient. Vogel VG, Surg Clin North Am 2003 83 733 751 10.1016/S0039-6109(03)00030-6 12875593 (Pubitemid 36841907)
20. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Ozanne EM, Klemp JR, Esserman LJ, Breast J 2006 12 103 113 10.1111/j.1075-122X.2006.00217.x 16509834
21. Pilot trial of a computerized decision aid for breast cancer prevention. Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L, Breast J 2007 13 147 154 10.1111/j.1524-4741.2007.00395.x 17319855 (Pubitemid 46280605)
22. Decision analysis: practice and promise. Howard RA, Manage Sci 1988 34 679 695 10.1287/mnsc.34.6.679
23. Howard R, Matheson J, The Principles and Applications of Decision Analysis Menlo Park, CA: Strategic Decisions Group 1 1989
24. Risk communication in clinical practice: putting cancer in context. Schwartz LM, Woloshin S, Welch HG, J Natl Cancer Inst Monogr 1999 100 12 845 853
25. Discussing breast cancer risk in primary care. Royak-Schaler R, Lemkau JP, Ahmed SM, J Am Med Womens Assoc 2002 57 115 116 11991420
26. Communicating breast cancer risks to women using different formats. Lipkus IM, Klein WM, Rimer BK, Cancer Epidemiol Biomarkers Prev 2001 10 895 898 11489757 (Pubitemid 32738603)
27. Graphs to estimate an individualized risk of breast cancer. Benichou J, Gail MH, Mulvihill JJ, J Clin Oncol 1996 14 103 110 8558184 (Pubitemid 26020002)
28. Explaining risks: turning numerical data into meaningful pictures. Edwards A, Elwyn G, Mulley A, BMJ 2002 324 827 830 10.1136/bmj.324.7341.827 11934777 (Pubitemid 34280736)
29. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ, J Natl Cancer Inst 1989 81 1879 1886 10.1093/jnci/81.24.1879 2593165 (Pubitemid 20026073)
30. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G, J Clin Oncol 2002 20 2701 2712 10.1200/JCO.2002.05.121 12039933 (Pubitemid 34575644)
31. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Claus EB, Risch N, Thompson WD, Breast Cancer Res Treat 1993 28 115 120 10.1007/BF00666424 8173064 (Pubitemid 24056083)
32. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K, Ann Intern Med 2008 148 337 347 10.7326/0003-4819-148-5-200803040-00004 18316752 (Pubitemid 351665464)
33. Personal Communication http://www.maya.com/
34. Assessing the quality of decision support technologies using the international patient decision aid standards instrument (IPDASi). Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, Durand M-A, Drake E, Joseph-Williams N, Khangura S, Saarimaki A, Sivell S, Stiel M, Bernstein SJ, Col N, Coulter A, Eden K, Härter M, Rovner MH, Moumjid N, Stacey D, Thomson R, Whelan T, van der Weijden T, Edwards A, PLoS One 2009 4 4705 10.1371/journal.pone.0004705 19259269
35. How to develop web-based decision support interventions for patients: a process map. Elwyn G, Kreuwel I, Durand MA, Sivell S, Joseph-Williams N, Evans R, Edwards A, Patient Educ Couns 2011 82 260 265 10.1016/j.pec.2010.04.034 20627644
36. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. Metcalfe KA, Narod SA, J Natl Cancer Inst 2002 94 1564 1569 10.1093/jnci/94.20.1564 12381709 (Pubitemid 35277280)